Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H27FN2O2 |
Molecular Weight | 345.4415 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)[C@H]1CCCC2=C1C3=C(OC)C=CC=C3N2CC[18F]
InChI
InChIKey=ZVDVQPLDTTXLKI-LSKWOKDISA-N
InChI=1S/C20H27FN2O2/c1-4-22(5-2)20(24)14-8-6-9-15-18(14)19-16(23(15)13-12-21)10-7-11-17(19)25-3/h7,10-11,14H,4-6,8-9,12-13H2,1-3H3/t14-/m0/s1/i21-1
Molecular Formula | C20H27FN2O2 |
Molecular Weight | 345.4415 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Flutriciclamide F18 (18F-GE-180), a translocator protein (TSPO)-PET radiotracer was used using in different pathologies. This agent was studied in phase I clinical trial to assess inflammation in rheumatoid arthritis. However, this study was terminated because of the pre-defined stopping criteria in the protocol.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02350426
18F-GE-180 solution for IV injection in 10mL glass vial. Patients will receive a maximum activity of 195 MBq in a maximum volume of 10 mL (bolus) of 18F-GE-180, containing not more than 2 microgram (mcg)/mL 18F-GE-180 (20 mcg for a 10 mL dose).
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:05:17 GMT 2023
by
admin
on
Sat Dec 16 08:05:17 GMT 2023
|
Record UNII |
M96ARL6373
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
51040949
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY | |||
|
9649
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY | |||
|
DB15380
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY | |||
|
1274863-98-7
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY | |||
|
300000037060
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY | |||
|
C174700
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY | |||
|
M96ARL6373
Created by
admin on Sat Dec 16 08:05:18 GMT 2023 , Edited by admin on Sat Dec 16 08:05:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
NON-LABELED -> LABELED |
|
||
|
TARGET->RADIOLIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|